Triple-negative breast cancer (TNBC) is recognized as a subtype of breast cancer in which three receptors [estrogen receptor (ER), progesterone receptor and human epidermal growth factor receptor 2] are negatively expressed on the surface of breast cancer cells (1,2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.